Global Neurotrophins Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Neurotrophins Industry Forecast” looks at past sales and reviews total world Neurotrophins sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurotrophins sales for 2023 through 2029. With Neurotrophins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurotrophins industry.
This Insight Report provides a comprehensive analysis of the global Neurotrophins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurotrophins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurotrophins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurotrophins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurotrophins.
The global Neurotrophins market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurotrophins players cover Johnson?Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech and GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurotrophins market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Neurotrophins market?
What factors are driving Neurotrophins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurotrophins market opportunities vary by end market size?
How does Neurotrophins break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Neurotrophins Industry Forecast” looks at past sales and reviews total world Neurotrophins sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurotrophins sales for 2023 through 2029. With Neurotrophins sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurotrophins industry.
This Insight Report provides a comprehensive analysis of the global Neurotrophins landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurotrophins portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurotrophins market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurotrophins and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurotrophins.
The global Neurotrophins market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neurotrophins is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neurotrophins players cover Johnson?Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech and GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurotrophins market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Nerve Growth Factor
- Brain-Derived Neurotrophic Factor
- Dehydroepiandrosterone Sulfate
- Other
- Alzheimer'S Disease
- Amyotrophic Lateral Sclerosis
- Parkinson'S Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson?Johnson
- Lonza Groups
- FibroGen
- Scil Proteins GmbH
- Merck Serono
- Scil Proteins GmbH
- PeproTech
- GE Healthcare
What is the 10-year outlook for the global Neurotrophins market?
What factors are driving Neurotrophins market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurotrophins market opportunities vary by end market size?
How does Neurotrophins break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurotrophins Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neurotrophins by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neurotrophins by Country/Region, 2018, 2022 & 2029
2.2 Neurotrophins Segment by Type
2.2.1 Nerve Growth Factor
2.2.2 Brain-Derived Neurotrophic Factor
2.2.3 Dehydroepiandrosterone Sulfate
2.2.4 Other
2.3 Neurotrophins Sales by Type
2.3.1 Global Neurotrophins Sales Market Share by Type (2018-2023)
2.3.2 Global Neurotrophins Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neurotrophins Sale Price by Type (2018-2023)
2.4 Neurotrophins Segment by Application
2.4.1 Alzheimer'S Disease
2.4.2 Amyotrophic Lateral Sclerosis
2.4.3 Parkinson'S Disease
2.4.4 Other
2.5 Neurotrophins Sales by Application
2.5.1 Global Neurotrophins Sale Market Share by Application (2018-2023)
2.5.2 Global Neurotrophins Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neurotrophins Sale Price by Application (2018-2023)
3 GLOBAL NEUROTROPHINS BY COMPANY
3.1 Global Neurotrophins Breakdown Data by Company
3.1.1 Global Neurotrophins Annual Sales by Company (2018-2023)
3.1.2 Global Neurotrophins Sales Market Share by Company (2018-2023)
3.2 Global Neurotrophins Annual Revenue by Company (2018-2023)
3.2.1 Global Neurotrophins Revenue by Company (2018-2023)
3.2.2 Global Neurotrophins Revenue Market Share by Company (2018-2023)
3.3 Global Neurotrophins Sale Price by Company
3.4 Key Manufacturers Neurotrophins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotrophins Product Location Distribution
3.4.2 Players Neurotrophins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROTROPHINS BY GEOGRAPHIC REGION
4.1 World Historic Neurotrophins Market Size by Geographic Region (2018-2023)
4.1.1 Global Neurotrophins Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neurotrophins Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neurotrophins Market Size by Country/Region (2018-2023)
4.2.1 Global Neurotrophins Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neurotrophins Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neurotrophins Sales Growth
4.4 APAC Neurotrophins Sales Growth
4.5 Europe Neurotrophins Sales Growth
4.6 Middle East & Africa Neurotrophins Sales Growth
5 AMERICAS
5.1 Americas Neurotrophins Sales by Country
5.1.1 Americas Neurotrophins Sales by Country (2018-2023)
5.1.2 Americas Neurotrophins Revenue by Country (2018-2023)
5.2 Americas Neurotrophins Sales by Type
5.3 Americas Neurotrophins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotrophins Sales by Region
6.1.1 APAC Neurotrophins Sales by Region (2018-2023)
6.1.2 APAC Neurotrophins Revenue by Region (2018-2023)
6.2 APAC Neurotrophins Sales by Type
6.3 APAC Neurotrophins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurotrophins by Country
7.1.1 Europe Neurotrophins Sales by Country (2018-2023)
7.1.2 Europe Neurotrophins Revenue by Country (2018-2023)
7.2 Europe Neurotrophins Sales by Type
7.3 Europe Neurotrophins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurotrophins by Country
8.1.1 Middle East & Africa Neurotrophins Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neurotrophins Revenue by Country (2018-2023)
8.2 Middle East & Africa Neurotrophins Sales by Type
8.3 Middle East & Africa Neurotrophins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotrophins
10.3 Manufacturing Process Analysis of Neurotrophins
10.4 Industry Chain Structure of Neurotrophins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotrophins Distributors
11.3 Neurotrophins Customer
12 WORLD FORECAST REVIEW FOR NEUROTROPHINS BY GEOGRAPHIC REGION
12.1 Global Neurotrophins Market Size Forecast by Region
12.1.1 Global Neurotrophins Forecast by Region (2024-2029)
12.1.2 Global Neurotrophins Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurotrophins Forecast by Type
12.7 Global Neurotrophins Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson?Johnson
13.1.1 Johnson?Johnson Company Information
13.1.2 Johnson?Johnson Neurotrophins Product Portfolios and Specifications
13.1.3 Johnson?Johnson Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson?Johnson Main Business Overview
13.1.5 Johnson?Johnson Latest Developments
13.2 Lonza Groups
13.2.1 Lonza Groups Company Information
13.2.2 Lonza Groups Neurotrophins Product Portfolios and Specifications
13.2.3 Lonza Groups Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lonza Groups Main Business Overview
13.2.5 Lonza Groups Latest Developments
13.3 FibroGen
13.3.1 FibroGen Company Information
13.3.2 FibroGen Neurotrophins Product Portfolios and Specifications
13.3.3 FibroGen Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 FibroGen Main Business Overview
13.3.5 FibroGen Latest Developments
13.4 Scil Proteins GmbH
13.4.1 Scil Proteins GmbH Company Information
13.4.2 Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
13.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Scil Proteins GmbH Main Business Overview
13.4.5 Scil Proteins GmbH Latest Developments
13.5 Merck Serono
13.5.1 Merck Serono Company Information
13.5.2 Merck Serono Neurotrophins Product Portfolios and Specifications
13.5.3 Merck Serono Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Serono Main Business Overview
13.5.5 Merck Serono Latest Developments
13.6 Scil Proteins GmbH
13.6.1 Scil Proteins GmbH Company Information
13.6.2 Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
13.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Scil Proteins GmbH Main Business Overview
13.6.5 Scil Proteins GmbH Latest Developments
13.7 PeproTech
13.7.1 PeproTech Company Information
13.7.2 PeproTech Neurotrophins Product Portfolios and Specifications
13.7.3 PeproTech Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 PeproTech Main Business Overview
13.7.5 PeproTech Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Neurotrophins Product Portfolios and Specifications
13.8.3 GE Healthcare Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurotrophins Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neurotrophins by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neurotrophins by Country/Region, 2018, 2022 & 2029
2.2 Neurotrophins Segment by Type
2.2.1 Nerve Growth Factor
2.2.2 Brain-Derived Neurotrophic Factor
2.2.3 Dehydroepiandrosterone Sulfate
2.2.4 Other
2.3 Neurotrophins Sales by Type
2.3.1 Global Neurotrophins Sales Market Share by Type (2018-2023)
2.3.2 Global Neurotrophins Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neurotrophins Sale Price by Type (2018-2023)
2.4 Neurotrophins Segment by Application
2.4.1 Alzheimer'S Disease
2.4.2 Amyotrophic Lateral Sclerosis
2.4.3 Parkinson'S Disease
2.4.4 Other
2.5 Neurotrophins Sales by Application
2.5.1 Global Neurotrophins Sale Market Share by Application (2018-2023)
2.5.2 Global Neurotrophins Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neurotrophins Sale Price by Application (2018-2023)
3 GLOBAL NEUROTROPHINS BY COMPANY
3.1 Global Neurotrophins Breakdown Data by Company
3.1.1 Global Neurotrophins Annual Sales by Company (2018-2023)
3.1.2 Global Neurotrophins Sales Market Share by Company (2018-2023)
3.2 Global Neurotrophins Annual Revenue by Company (2018-2023)
3.2.1 Global Neurotrophins Revenue by Company (2018-2023)
3.2.2 Global Neurotrophins Revenue Market Share by Company (2018-2023)
3.3 Global Neurotrophins Sale Price by Company
3.4 Key Manufacturers Neurotrophins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotrophins Product Location Distribution
3.4.2 Players Neurotrophins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEUROTROPHINS BY GEOGRAPHIC REGION
4.1 World Historic Neurotrophins Market Size by Geographic Region (2018-2023)
4.1.1 Global Neurotrophins Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neurotrophins Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neurotrophins Market Size by Country/Region (2018-2023)
4.2.1 Global Neurotrophins Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neurotrophins Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neurotrophins Sales Growth
4.4 APAC Neurotrophins Sales Growth
4.5 Europe Neurotrophins Sales Growth
4.6 Middle East & Africa Neurotrophins Sales Growth
5 AMERICAS
5.1 Americas Neurotrophins Sales by Country
5.1.1 Americas Neurotrophins Sales by Country (2018-2023)
5.1.2 Americas Neurotrophins Revenue by Country (2018-2023)
5.2 Americas Neurotrophins Sales by Type
5.3 Americas Neurotrophins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotrophins Sales by Region
6.1.1 APAC Neurotrophins Sales by Region (2018-2023)
6.1.2 APAC Neurotrophins Revenue by Region (2018-2023)
6.2 APAC Neurotrophins Sales by Type
6.3 APAC Neurotrophins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurotrophins by Country
7.1.1 Europe Neurotrophins Sales by Country (2018-2023)
7.1.2 Europe Neurotrophins Revenue by Country (2018-2023)
7.2 Europe Neurotrophins Sales by Type
7.3 Europe Neurotrophins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurotrophins by Country
8.1.1 Middle East & Africa Neurotrophins Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neurotrophins Revenue by Country (2018-2023)
8.2 Middle East & Africa Neurotrophins Sales by Type
8.3 Middle East & Africa Neurotrophins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotrophins
10.3 Manufacturing Process Analysis of Neurotrophins
10.4 Industry Chain Structure of Neurotrophins
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotrophins Distributors
11.3 Neurotrophins Customer
12 WORLD FORECAST REVIEW FOR NEUROTROPHINS BY GEOGRAPHIC REGION
12.1 Global Neurotrophins Market Size Forecast by Region
12.1.1 Global Neurotrophins Forecast by Region (2024-2029)
12.1.2 Global Neurotrophins Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurotrophins Forecast by Type
12.7 Global Neurotrophins Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Johnson?Johnson
13.1.1 Johnson?Johnson Company Information
13.1.2 Johnson?Johnson Neurotrophins Product Portfolios and Specifications
13.1.3 Johnson?Johnson Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson?Johnson Main Business Overview
13.1.5 Johnson?Johnson Latest Developments
13.2 Lonza Groups
13.2.1 Lonza Groups Company Information
13.2.2 Lonza Groups Neurotrophins Product Portfolios and Specifications
13.2.3 Lonza Groups Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Lonza Groups Main Business Overview
13.2.5 Lonza Groups Latest Developments
13.3 FibroGen
13.3.1 FibroGen Company Information
13.3.2 FibroGen Neurotrophins Product Portfolios and Specifications
13.3.3 FibroGen Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 FibroGen Main Business Overview
13.3.5 FibroGen Latest Developments
13.4 Scil Proteins GmbH
13.4.1 Scil Proteins GmbH Company Information
13.4.2 Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
13.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Scil Proteins GmbH Main Business Overview
13.4.5 Scil Proteins GmbH Latest Developments
13.5 Merck Serono
13.5.1 Merck Serono Company Information
13.5.2 Merck Serono Neurotrophins Product Portfolios and Specifications
13.5.3 Merck Serono Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Serono Main Business Overview
13.5.5 Merck Serono Latest Developments
13.6 Scil Proteins GmbH
13.6.1 Scil Proteins GmbH Company Information
13.6.2 Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
13.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Scil Proteins GmbH Main Business Overview
13.6.5 Scil Proteins GmbH Latest Developments
13.7 PeproTech
13.7.1 PeproTech Company Information
13.7.2 PeproTech Neurotrophins Product Portfolios and Specifications
13.7.3 PeproTech Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 PeproTech Main Business Overview
13.7.5 PeproTech Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Neurotrophins Product Portfolios and Specifications
13.8.3 GE Healthcare Neurotrophins Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurotrophins Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neurotrophins Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nerve Growth Factor
Table 4. Major Players of Brain-Derived Neurotrophic Factor
Table 5. Major Players of Dehydroepiandrosterone Sulfate
Table 6. Major Players of Other
Table 7. Global Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 8. Global Neurotrophins Sales Market Share by Type (2018-2023)
Table 9. Global Neurotrophins Revenue by Type (2018-2023) & ($ million)
Table 10. Global Neurotrophins Revenue Market Share by Type (2018-2023)
Table 11. Global Neurotrophins Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 13. Global Neurotrophins Sales Market Share by Application (2018-2023)
Table 14. Global Neurotrophins Revenue by Application (2018-2023)
Table 15. Global Neurotrophins Revenue Market Share by Application (2018-2023)
Table 16. Global Neurotrophins Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Neurotrophins Sales by Company (2018-2023) & (K Units)
Table 18. Global Neurotrophins Sales Market Share by Company (2018-2023)
Table 19. Global Neurotrophins Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Neurotrophins Revenue Market Share by Company (2018-2023)
Table 21. Global Neurotrophins Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Neurotrophins Producing Area Distribution and Sales Area
Table 23. Players Neurotrophins Products Offered
Table 24. Neurotrophins Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Neurotrophins Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Neurotrophins Sales Market Share Geographic Region (2018-2023)
Table 29. Global Neurotrophins Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Neurotrophins Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Neurotrophins Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Neurotrophins Sales Market Share by Country/Region (2018-2023)
Table 33. Global Neurotrophins Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Neurotrophins Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 36. Americas Neurotrophins Sales Market Share by Country (2018-2023)
Table 37. Americas Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Neurotrophins Revenue Market Share by Country (2018-2023)
Table 39. Americas Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 40. Americas Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 41. APAC Neurotrophins Sales by Region (2018-2023) & (K Units)
Table 42. APAC Neurotrophins Sales Market Share by Region (2018-2023)
Table 43. APAC Neurotrophins Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Neurotrophins Revenue Market Share by Region (2018-2023)
Table 45. APAC Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 46. APAC Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 47. Europe Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 48. Europe Neurotrophins Sales Market Share by Country (2018-2023)
Table 49. Europe Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Neurotrophins Revenue Market Share by Country (2018-2023)
Table 51. Europe Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 52. Europe Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Neurotrophins Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Neurotrophins Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Neurotrophins
Table 60. Key Market Challenges & Risks of Neurotrophins
Table 61. Key Industry Trends of Neurotrophins
Table 62. Neurotrophins Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Neurotrophins Distributors List
Table 65. Neurotrophins Customer List
Table 66. Global Neurotrophins Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Neurotrophins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Neurotrophins Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Neurotrophins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Neurotrophins Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Neurotrophins Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Neurotrophins Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Neurotrophins Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Johnson?Johnson Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson?Johnson Neurotrophins Product Portfolios and Specifications
Table 82. Johnson?Johnson Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson?Johnson Main Business
Table 84. Johnson?Johnson Latest Developments
Table 85. Lonza Groups Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 86. Lonza Groups Neurotrophins Product Portfolios and Specifications
Table 87. Lonza Groups Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lonza Groups Main Business
Table 89. Lonza Groups Latest Developments
Table 90. FibroGen Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 91. FibroGen Neurotrophins Product Portfolios and Specifications
Table 92. FibroGen Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. FibroGen Main Business
Table 94. FibroGen Latest Developments
Table 95. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 96. Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
Table 97. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Scil Proteins GmbH Main Business
Table 99. Scil Proteins GmbH Latest Developments
Table 100. Merck Serono Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Serono Neurotrophins Product Portfolios and Specifications
Table 102. Merck Serono Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck Serono Main Business
Table 104. Merck Serono Latest Developments
Table 105. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 106. Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
Table 107. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Scil Proteins GmbH Main Business
Table 109. Scil Proteins GmbH Latest Developments
Table 110. PeproTech Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 111. PeproTech Neurotrophins Product Portfolios and Specifications
Table 112. PeproTech Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. PeproTech Main Business
Table 114. PeproTech Latest Developments
Table 115. GE Healthcare Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 116. GE Healthcare Neurotrophins Product Portfolios and Specifications
Table 117. GE Healthcare Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. GE Healthcare Main Business
Table 119. GE Healthcare Latest Developments
Table 1. Neurotrophins Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neurotrophins Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nerve Growth Factor
Table 4. Major Players of Brain-Derived Neurotrophic Factor
Table 5. Major Players of Dehydroepiandrosterone Sulfate
Table 6. Major Players of Other
Table 7. Global Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 8. Global Neurotrophins Sales Market Share by Type (2018-2023)
Table 9. Global Neurotrophins Revenue by Type (2018-2023) & ($ million)
Table 10. Global Neurotrophins Revenue Market Share by Type (2018-2023)
Table 11. Global Neurotrophins Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 13. Global Neurotrophins Sales Market Share by Application (2018-2023)
Table 14. Global Neurotrophins Revenue by Application (2018-2023)
Table 15. Global Neurotrophins Revenue Market Share by Application (2018-2023)
Table 16. Global Neurotrophins Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Neurotrophins Sales by Company (2018-2023) & (K Units)
Table 18. Global Neurotrophins Sales Market Share by Company (2018-2023)
Table 19. Global Neurotrophins Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Neurotrophins Revenue Market Share by Company (2018-2023)
Table 21. Global Neurotrophins Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Neurotrophins Producing Area Distribution and Sales Area
Table 23. Players Neurotrophins Products Offered
Table 24. Neurotrophins Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Neurotrophins Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Neurotrophins Sales Market Share Geographic Region (2018-2023)
Table 29. Global Neurotrophins Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Neurotrophins Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Neurotrophins Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Neurotrophins Sales Market Share by Country/Region (2018-2023)
Table 33. Global Neurotrophins Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Neurotrophins Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 36. Americas Neurotrophins Sales Market Share by Country (2018-2023)
Table 37. Americas Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Neurotrophins Revenue Market Share by Country (2018-2023)
Table 39. Americas Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 40. Americas Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 41. APAC Neurotrophins Sales by Region (2018-2023) & (K Units)
Table 42. APAC Neurotrophins Sales Market Share by Region (2018-2023)
Table 43. APAC Neurotrophins Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Neurotrophins Revenue Market Share by Region (2018-2023)
Table 45. APAC Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 46. APAC Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 47. Europe Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 48. Europe Neurotrophins Sales Market Share by Country (2018-2023)
Table 49. Europe Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Neurotrophins Revenue Market Share by Country (2018-2023)
Table 51. Europe Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 52. Europe Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Neurotrophins Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Neurotrophins Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Neurotrophins Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Neurotrophins Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Neurotrophins Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Neurotrophins Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Neurotrophins
Table 60. Key Market Challenges & Risks of Neurotrophins
Table 61. Key Industry Trends of Neurotrophins
Table 62. Neurotrophins Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Neurotrophins Distributors List
Table 65. Neurotrophins Customer List
Table 66. Global Neurotrophins Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Neurotrophins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Neurotrophins Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Neurotrophins Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Neurotrophins Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Neurotrophins Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Neurotrophins Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Neurotrophins Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Neurotrophins Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Neurotrophins Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Johnson?Johnson Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 81. Johnson?Johnson Neurotrophins Product Portfolios and Specifications
Table 82. Johnson?Johnson Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson?Johnson Main Business
Table 84. Johnson?Johnson Latest Developments
Table 85. Lonza Groups Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 86. Lonza Groups Neurotrophins Product Portfolios and Specifications
Table 87. Lonza Groups Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Lonza Groups Main Business
Table 89. Lonza Groups Latest Developments
Table 90. FibroGen Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 91. FibroGen Neurotrophins Product Portfolios and Specifications
Table 92. FibroGen Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. FibroGen Main Business
Table 94. FibroGen Latest Developments
Table 95. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 96. Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
Table 97. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Scil Proteins GmbH Main Business
Table 99. Scil Proteins GmbH Latest Developments
Table 100. Merck Serono Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Serono Neurotrophins Product Portfolios and Specifications
Table 102. Merck Serono Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck Serono Main Business
Table 104. Merck Serono Latest Developments
Table 105. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 106. Scil Proteins GmbH Neurotrophins Product Portfolios and Specifications
Table 107. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Scil Proteins GmbH Main Business
Table 109. Scil Proteins GmbH Latest Developments
Table 110. PeproTech Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 111. PeproTech Neurotrophins Product Portfolios and Specifications
Table 112. PeproTech Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. PeproTech Main Business
Table 114. PeproTech Latest Developments
Table 115. GE Healthcare Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 116. GE Healthcare Neurotrophins Product Portfolios and Specifications
Table 117. GE Healthcare Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. GE Healthcare Main Business
Table 119. GE Healthcare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurotrophins
Figure 2. Neurotrophins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurotrophins Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Neurotrophins Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neurotrophins Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nerve Growth Factor
Figure 10. Product Picture of Brain-Derived Neurotrophic Factor
Figure 11. Product Picture of Dehydroepiandrosterone Sulfate
Figure 12. Product Picture of Other
Figure 13. Global Neurotrophins Sales Market Share by Type in 2022
Figure 14. Global Neurotrophins Revenue Market Share by Type (2018-2023)
Figure 15. Neurotrophins Consumed in Alzheimer'S Disease
Figure 16. Global Neurotrophins Market: Alzheimer'S Disease (2018-2023) & (K Units)
Figure 17. Neurotrophins Consumed in Amyotrophic Lateral Sclerosis
Figure 18. Global Neurotrophins Market: Amyotrophic Lateral Sclerosis (2018-2023) & (K Units)
Figure 19. Neurotrophins Consumed in Parkinson'S Disease
Figure 20. Global Neurotrophins Market: Parkinson'S Disease (2018-2023) & (K Units)
Figure 21. Neurotrophins Consumed in Other
Figure 22. Global Neurotrophins Market: Other (2018-2023) & (K Units)
Figure 23. Global Neurotrophins Sales Market Share by Application (2022)
Figure 24. Global Neurotrophins Revenue Market Share by Application in 2022
Figure 25. Neurotrophins Sales Market by Company in 2022 (K Units)
Figure 26. Global Neurotrophins Sales Market Share by Company in 2022
Figure 27. Neurotrophins Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Neurotrophins Revenue Market Share by Company in 2022
Figure 29. Global Neurotrophins Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Neurotrophins Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Neurotrophins Sales 2018-2023 (K Units)
Figure 32. Americas Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 33. APAC Neurotrophins Sales 2018-2023 (K Units)
Figure 34. APAC Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 35. Europe Neurotrophins Sales 2018-2023 (K Units)
Figure 36. Europe Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Neurotrophins Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 39. Americas Neurotrophins Sales Market Share by Country in 2022
Figure 40. Americas Neurotrophins Revenue Market Share by Country in 2022
Figure 41. Americas Neurotrophins Sales Market Share by Type (2018-2023)
Figure 42. Americas Neurotrophins Sales Market Share by Application (2018-2023)
Figure 43. United States Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Neurotrophins Sales Market Share by Region in 2022
Figure 48. APAC Neurotrophins Revenue Market Share by Regions in 2022
Figure 49. APAC Neurotrophins Sales Market Share by Type (2018-2023)
Figure 50. APAC Neurotrophins Sales Market Share by Application (2018-2023)
Figure 51. China Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Neurotrophins Sales Market Share by Country in 2022
Figure 59. Europe Neurotrophins Revenue Market Share by Country in 2022
Figure 60. Europe Neurotrophins Sales Market Share by Type (2018-2023)
Figure 61. Europe Neurotrophins Sales Market Share by Application (2018-2023)
Figure 62. Germany Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Neurotrophins Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Neurotrophins Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Neurotrophins Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Neurotrophins Sales Market Share by Application (2018-2023)
Figure 71. Egypt Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Neurotrophins in 2022
Figure 77. Manufacturing Process Analysis of Neurotrophins
Figure 78. Industry Chain Structure of Neurotrophins
Figure 79. Channels of Distribution
Figure 80. Global Neurotrophins Sales Market Forecast by Region (2024-2029)
Figure 81. Global Neurotrophins Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Neurotrophins Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Neurotrophins Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Neurotrophins Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Neurotrophins Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Neurotrophins
Figure 2. Neurotrophins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurotrophins Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Neurotrophins Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neurotrophins Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nerve Growth Factor
Figure 10. Product Picture of Brain-Derived Neurotrophic Factor
Figure 11. Product Picture of Dehydroepiandrosterone Sulfate
Figure 12. Product Picture of Other
Figure 13. Global Neurotrophins Sales Market Share by Type in 2022
Figure 14. Global Neurotrophins Revenue Market Share by Type (2018-2023)
Figure 15. Neurotrophins Consumed in Alzheimer'S Disease
Figure 16. Global Neurotrophins Market: Alzheimer'S Disease (2018-2023) & (K Units)
Figure 17. Neurotrophins Consumed in Amyotrophic Lateral Sclerosis
Figure 18. Global Neurotrophins Market: Amyotrophic Lateral Sclerosis (2018-2023) & (K Units)
Figure 19. Neurotrophins Consumed in Parkinson'S Disease
Figure 20. Global Neurotrophins Market: Parkinson'S Disease (2018-2023) & (K Units)
Figure 21. Neurotrophins Consumed in Other
Figure 22. Global Neurotrophins Market: Other (2018-2023) & (K Units)
Figure 23. Global Neurotrophins Sales Market Share by Application (2022)
Figure 24. Global Neurotrophins Revenue Market Share by Application in 2022
Figure 25. Neurotrophins Sales Market by Company in 2022 (K Units)
Figure 26. Global Neurotrophins Sales Market Share by Company in 2022
Figure 27. Neurotrophins Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Neurotrophins Revenue Market Share by Company in 2022
Figure 29. Global Neurotrophins Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Neurotrophins Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Neurotrophins Sales 2018-2023 (K Units)
Figure 32. Americas Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 33. APAC Neurotrophins Sales 2018-2023 (K Units)
Figure 34. APAC Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 35. Europe Neurotrophins Sales 2018-2023 (K Units)
Figure 36. Europe Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Neurotrophins Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Neurotrophins Revenue 2018-2023 ($ Millions)
Figure 39. Americas Neurotrophins Sales Market Share by Country in 2022
Figure 40. Americas Neurotrophins Revenue Market Share by Country in 2022
Figure 41. Americas Neurotrophins Sales Market Share by Type (2018-2023)
Figure 42. Americas Neurotrophins Sales Market Share by Application (2018-2023)
Figure 43. United States Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Neurotrophins Sales Market Share by Region in 2022
Figure 48. APAC Neurotrophins Revenue Market Share by Regions in 2022
Figure 49. APAC Neurotrophins Sales Market Share by Type (2018-2023)
Figure 50. APAC Neurotrophins Sales Market Share by Application (2018-2023)
Figure 51. China Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Neurotrophins Sales Market Share by Country in 2022
Figure 59. Europe Neurotrophins Revenue Market Share by Country in 2022
Figure 60. Europe Neurotrophins Sales Market Share by Type (2018-2023)
Figure 61. Europe Neurotrophins Sales Market Share by Application (2018-2023)
Figure 62. Germany Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Neurotrophins Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Neurotrophins Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Neurotrophins Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Neurotrophins Sales Market Share by Application (2018-2023)
Figure 71. Egypt Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Neurotrophins Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Neurotrophins in 2022
Figure 77. Manufacturing Process Analysis of Neurotrophins
Figure 78. Industry Chain Structure of Neurotrophins
Figure 79. Channels of Distribution
Figure 80. Global Neurotrophins Sales Market Forecast by Region (2024-2029)
Figure 81. Global Neurotrophins Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Neurotrophins Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Neurotrophins Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Neurotrophins Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Neurotrophins Revenue Market Share Forecast by Application (2024-2029)
